The Senate health committee has effectively killed the Trump administration's bid to install Jim O'Neill as head of the National Science Foundation, a move that came just hours after the White House withdrew its FDA nominee. Chairman Bill Cassidy (R-La.) announced Wednesday that O'Neill lacked the votes to advance, canceling a scheduled committee vote.

Cassidy, a physician and frequent critic of administration health policies, said O'Neill "did not do enough to stand up for science and against irresponsible decisions and statements from [HHS Secretary Robert F. Kennedy Jr.]." He also pointed to O'Neill's role in the firing of Dr. Susan Monarez as CDC director, saying it raised "concerns about the independent judgment he would bring to NSF."

Read also
Politics
Baltimore Mayor Demands Action After Ravens Star's 'Criminals' Remark
Baltimore's mayor rejected Marlon Humphrey's apology for saying the city is best at making 'criminals,' insisting on a meeting and tangible action.

Monarez was ousted just a month after her confirmation, allegedly for refusing to endorse Kennedy's unproven vaccine recommendations or to dismiss staff without cause. O'Neill briefly took over as acting CDC director while serving as HHS deputy secretary, before being replaced in a broader agency shakeup and nominated for the NSF post.

"I like Jim personally, but this time requires leadership and fortitude and standing up for what is right," Cassidy said during the committee's meeting, according to prepared remarks.

O'Neill, a venture capitalist and longtime associate of Peter Thiel, has no formal science background. His nomination faced skepticism from both Democrats and some Republicans concerned about political interference in independent research funding. The NSF has been without a Senate-confirmed leader since April 2025, when Sethuraman Panchanathan resigned amid the administration's efforts to cancel hundreds of millions in grants and slash the agency's budget. Trump also removed all members of the National Science Board earlier that month.

Cassidy, who lost his primary to a Trump-backed challenger earlier this year, has drawn sharp criticism from public health experts for his pivotal vote to confirm Kennedy as HHS secretary. On Wednesday, he noted that his committee would have supported Heidi Overton to lead the FDA despite concerns about her vaccine stance, but the White House pulled her nomination before a vote.

The rejection of O'Neill marks a rare bipartisan pushback against Trump's personnel moves in science agencies. It also highlights growing tension between the administration and Senate Republicans over the direction of federal research and public health policy. The NSF's future leadership remains uncertain as the agency continues to operate under acting officials.

Political observers see this as a test of whether Congress will assert its oversight role amid broader efforts to reshape the federal bureaucracy. The decision could have lasting implications for how basic research is funded and prioritized in the coming years.